Cybin CEO Doug Drysdale joins Jay Coulter and Chris Versace for this installment of the Investment Spotlight Series from Resilient Advisor.
About Cybin (from Cybin.com):
Cybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders.
Podcast
Sound Bites
Connect With Doug:
LinkedIn: https://www.linkedin.com/in/dougdrysdale
Twitter: https://twitter.com/insidepharma
Learn More About Cybin:
Website: https://www.cybin.com
LinkedIn: https://www.linkedin.com/company/cybin
Twitter: https://twitter.com/CybinInc
Facebook: https://www.facebook.com/cybinInc
Comentarios